Moderna (MRNA) has had the highest return since June 2, 2026 by a US stock with a market cap of $10B+, returning 399%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 399.01% |
PBF Energy (PBF) | 116.12% |
Atlassian (TEAM) | 97.99% |
Marathon Petroleum (MPC) | 89.19% |
Xp (XP) | 86.96% |
Natera (NTRA) | 83.78% |
HF Sinclair (DINO) | 83.18% |
Valero Energy (VLO) | 81.59% |
Frontline (FRO) | 79.49% |
Avantor (AVTR) | 78.61% |
Halozyme Therapeutics (HALO) | 73.37% |
Bending Spoons SpA (BSP) | 72.45% |
Charles River Laboratories (CRL) | 68.72% |
Illumina (ILMN) | 68.54% |
Everpure (P) | 66.77% |
Phillips 66 (PSX) | 66.46% |
Paycom Software (PAYC) | 66.11% |
Corcept Therapeutics (CORT) | 66.04% |
Okta (OKTA) | 63.01% |
Veeva Systems Inc Class A (VEEV) | 60.96% |
Tenet Healthcare (THC) | 59.48% |
Revvity (RVTY) | 54.63% |
Chime Financial, Inc Class A Common Stock (CHYM) | 52.71% |
Genmab A-S (GMAB) | 52.53% |
SharkNinja (SN) | 51.85% |